news
CEPI announces three programmes to develop coronavirus vaccine
The CEPI has announced three respective projects with Inovio, the University of Queensland and Moderna, to develop a vaccine for the novel coronavirus, nCoV-2019.
List view / Grid view
University of Queensland
article
What is label-free screening and why use it in drug discovery?
18 December 2012 | By Matthew A. Cooper and Reena Halai, Institute for Molecular Bioscience, the University of Queensland
In the journey of a molecule from its origins in a compound library to candidate drug status, a large variety of profiling must occur to define activity, selectivity, potency, adverse effects, pharmacology and in vivo efficacy. Advances in biophysical methods that can analyse drug interactions with a molecular target, a…
news
Novozymes Biopharma to present latest advances in cell culture technology at ESACT
12 April 2011 | By The Scott Partnership
Novozymes Biopharma, will present two scientific posters at the 2011 ESACT meeting...
